$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Tissues are comprised of a diverse set of cells with specialized functions that organize into three-dimensional structures and, through interaction, coordinate the biological processes that are necessary for life. Pathology arises when disruptions to the cellular composition or tissue architecture interfere with these interactions and compromise tissue homeostasis1. Knowledge of how the numerous specialized cell types localize and interact within our tissues is required in order to understand the biology that underlies human health and disease.
Advances in single-cell profiling technologies at the transcriptomic, epigenomic, and proteomic levels have uncovered an exceptional diversity of specialized cell types.2,3 Technologies such as single-cell RNA sequencing and spectral flow cytometry can measure the number of parameters required to characterize these heterogeneous populations. However, these approaches lack spatial information, as cells must be dissociated from their native tissue environment into single-cell suspensions4,5. As such, cell types associated with various disease contexts have been identified, but their interactions within the tissue and their contribution to perpetuating disease remain unclear.
To address some of these limitations, several spatial-omics technologies have been developed to capture cellular heterogeneity within a tissue while also preserving the position of each cell6. For example, gene transcription can be measured either by amplifying RNA at rasterized spots across a tissue section (e.g., Visium) or by using RNA hybridization probes targeting a panel of specific genes that are imaged at single-cell resolution (e.g., Xenium)7,8. These methods are effective for tracing transcriptional patterns and regulatory mechanisms within tissues. However, transcriptional profiles often poorly correlate with protein expression, which more directly reflects the functional capabilities of a cell9. Protein expression can be identified using specific antibodies conjugated to fluorophores, which can be detected by fluorescence microscopy10,11. The use of traditional fluorescence microscopy can allow for discrete imaging of upwards of six such antibody-conjugated fluorophores. However, the overlapping excitation and emission profiles of these fluorophores result in uncertainty as to the origin of the fluorescence signal in any given channel12.
Iterative Bleaching Extends multipleXity (IBEX) is a high-content imaging method that was developed to overcome this limitation of fluorescence microscopy13,14,15. IBEX uses lithium borohydride (LiBH4) to chemically inactivate fluorophores after imaging, allowing for the same tissue sample to be re-stained with a subsequent round of fluorophore-conjugated antibodies prior to re-imaging. IBEX preserves tissue integrity, enabling many rounds of imaging to visualize a theoretically unlimited number of markers on the same tissue section. Computational alignment of the acquired images provides omics-level characterization at single-cell resolution while preserving spatial data to reveal cellular niches. This data can also reveal putative cellular interactions, though these should be validated using other techniques16. IBEX is an open-source method that is compatible with commercially available fluorophores and is supported by an international community of researchers who have validated reagents and share data publicly to promote accessibility, rapid adoption, and high-quality data generation17,18.
In this work, a modified protocol of IBEX has been designed to overcome two major challenges of the technique: tissue autofluorescence and non-specific binding of fluorophore-conjugated antibody probes (collectively referred to as background). Autofluorescence arises when excitation of fluorescent molecules endogenous to a tissue emits light that overlaps with the desired signal obtained from antibody-conjugated fluorophores19,20. Off-target or non-specific binding of fluorophore-conjugated antibodies results in fluorescence from cells or structures that do not express the target protein21,22. These artifacts can result in the inaccurate conclusion that a cell expresses a marker that it does not truly express, thus complicating computational analyses and accurate cell-type assignment. By combining heparin-based charge neutralization of off-target signal with full-spectral acquisition and computational unmixing, spectral IBEX markedly reduces bleed-through, improves signal-to-background ratio (SBR), and halves per-round acquisition time.